HRT Financial’s Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share ZGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,166
Closed -$31K 3779
2022
Q2
$31K Sell
20,166
-12,346
-38% -$22.4K ﹤0.01% 2565
2022
Q1
$72K Sell
32,512
-990
-3% -$2.02K ﹤0.01% 2711
2021
Q4
$67K Buy
+33,502
New +$69.3K ﹤0.01% 2812

Other funds holding ZGN.WS

HRT Financial's ZGN.WS Position: Q3 2022 in Review

HRT Financial sold out of Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share (ZGN.WS) in Q3 2022, closing a stake of 20,166 shares — an estimated $31K sold.

HRT Financial first reported a position in ZGN.WS in Q4 2021 and held it in 3 quarters. The position peaked at $72K in Q1 2022. 16 funds tracked by Wall St. Rank hold ZGN.WS as of Q3 2022.

  • HRT Financial reported no remaining Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 20,166 Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share shares in Q3 2022, an estimated $31K.
  • HRT Financial first reported a position in Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position peaked at $72K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.